期刊文献+

硝酸异山梨酯对高龄慢性阻塞性肺疾病并发慢性心衰的治疗价值 被引量:1

Therapeutic value of isosorbide dinitrate for elderly patients with chronic obstructive pulmonary disease complicated with chronic heart failure
原文传递
导出
摘要 目的探讨硝酸异山梨酯对高龄慢阻肺并发慢性心衰的治疗价值。方法将218例高龄慢阻肺并发慢性心衰患者随机分为两组,对照组给予常规治疗,观察组在常规治疗基础上加用硝酸异山梨酯,比较两组治疗效果。结果观察组治疗总有效率为90.83%,明显高于对照组(P<0.01);治疗后观察组Pa O2、Pa CO2较对照组改善更明显(P<0.01);观察组治疗后心功能有明显改善(P<0.01);治疗后两组患者肺功能均有明显改善(P<0.01)。结论硝酸异山梨酯治疗高龄慢阻肺并发慢性心衰疗效显著,可有效改善患者的心功能,值得推广。 Objective To investigate therapeutic value of isosorbide dinitrate for elderly patients with chronic obstructive pulmonary disease complicated with chronic heart failure. Methods 218 cases of elderly patients with chronic obstructive pulmonary disease complicated with chronic heart failure were randomly divided into two groups,control group were given conventional treatment,observation group were plus isosorbide dinitrate on the basis of conventional therapy,therapeutic effects of two groups were compared. Results The total effective rate of observation group was 90. 83%,significantly higher than control group P〈0. 01; After treatment,improvement of PaO2,PaCO2 of observation group were more significant than control group P〈0. 01; Cardiac function of observation group after treatment significantly improved P〈0. 01) after treatment,two groups of patients showed significant improvement in lung function P〈0. 01. Conclusion Isosorbide dinitrate treatment of elderly patients with chronic obstructive pulmonary disease complicated with chronic heart failure can effectively improve cardiac function,worthy of promotion.
作者 潘木源
出处 《辽宁医学杂志》 2016年第2期15-16,共2页 Medical Journal of Liaoning
关键词 硝酸异山梨酯 慢阻肺 慢性心衰 Isosorbide dinitrate Chronic obstructive pulmonary disease Chronic heart failure
  • 相关文献

参考文献4

二级参考文献35

  • 1柳涛,蔡柏蔷.慢性阻塞性肺疾病患者生活质量评估方法及其意义[J].中国呼吸与危重监护杂志,2003,2(4):196-197. 被引量:54
  • 2曹雅旻,胡大一,王宏宇,吴彦.我国基层医院慢性心力衰竭药物治疗现状调查[J].中华内科杂志,2006,45(11):907-909. 被引量:72
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8251
  • 4王耀锋.脉络宁治疗COPD并肺心病心衰疗效观察[J].临床肺科杂志,2007,12(9):922-923. 被引量:2
  • 5叶任高 陆再英主编.内科学[M]第5版[M].北京:人民卫生出版社,2000.475.
  • 6Curkendall SM, Deluise C, Jones JK,et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients[J]. Ann Epidemiol,2006,16 ( 1 ) : 63-70.
  • 7Farrell MH, Foody J M, Krumholz HM. beta blockers in heart failure: clinical applications[J]. JAMA 2002, 287 ( 7 ) : 890- 897.
  • 8Remme W J, Swedberg K, et al. Guidelines for the diagnosis and treatment of chronic heart failure[J]. Eur Heart J,2001, 22(17) :1527-1560.
  • 9Salpeter S, Ormiston T, Salpeter E. Cardioselective beta- blockers for chronic obstructive pulmonary disease [J]. Cochrane Database Syst Rev, 2005,19 (4) : CD003566.
  • 10Jabbour A, Macdonald PS, Keogh AM, et al. Differences between beta blockers in patients with chronic heart failure and chronic obstructive pulmonary disease [J]. J Am Coll Cardiol,2010,55(17) : 1780- 1787.

共引文献48

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部